Aurora

Researchers are evaluating the effects of adult day programs on older adults living with dementia and their family or friend caregivers across four Canadian provinces Alberta, British Columbia, Manitoba, and Ontario. The study aims to understand how day program attendance influences the quality of life and mental health of attendees and caregivers, as well as how different program characteristics and social identities relate to these outcomes. This observational study compares day program users and non-users to explore patterns of care and health outcomes in this population. Participants include older adults aged 65 and above with dementia who either attend an adult day program or receive other community-based continuing care services, along with their primary caregivers. The study gathers comprehensive data through surveys at baseline and follow-ups after one and two years, combined with health administrative records. Day program characteristics such as staffing and programming will be assessed, and participants will be grouped by levels of day program usage. During the study, participants will complete quality of life and mental health surveys at the start and at one- and two-year intervals. Researchers will also track cognitive and physical changes, time to admission into continuing care homes, and healthcare use including emergency visits and hospital stays over up to 2.5 years. This comprehensive approach aims to provide a detailed understanding of how adult day programs support older adults with dementia and their caregivers over time.

Researchers are conducting a non-interventional, observational study to collect real-world data on the use of an autologous hair follicle derived secretome topical cosmetic product as an adjunct following various medical aesthetic procedures. The study focuses on adults aged 18 to 60 undergoing these procedures and aims to better understand post-procedural symptoms and recovery. Participants plan to use the Acorn Autologous Hair Follicle Secretome cosmetic product after medical aesthetic treatments such as laser resurfacing, microneedling, and other related procedures. The study includes individuals with different Fitzpatrick skin types and those receiving hair procedures with stable hair loss medication use. Some specific hair and scalp treatments are closed to enrollment. During the study, participants will be observed for post-procedure symptoms and will complete downtime questionnaires for 1 to 7 days following their procedures. Researchers will gather data on recovery and any side effects experienced. The study is open-label, multi-site, and will follow participants over time to monitor outcomes related to the product use and aesthetic treatments.